WORLDSymposium 2016 New Treatment Award

Each year WORLDSymposium recognizes important achievements in therapy for lysosomal diseases. In 2016 one new treatment was recognized for achieving regulatory approval. The New Treatment Award went to sebelipase alfa (Kanum™) which provided clinical data meriting approval by the European Medicines Agency and by the U.S. Food and Drug Administration.